The 20 Best Muscle Invasive Bladder Cancer Doctors Near Me in Brighton, MI

Fadi Eliya is a Urologist practicing medicine in Brighton, Michigan. He has been practicing medicine for over 22 years. Dr. Eliya is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 59 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Ureteroscopy, and Prostatectomy. Dr. Eliya is board certified in American Board Of Urology. Dr. Eliya is currently accepting new patients.

Samuel Kaffenberger is a Urologist practicing medicine in Brighton, Michigan. He has been practicing medicine for over 17 years. Dr. Kaffenberger is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Bladder Cancer, Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Kaffenberger is board certified in Urology.

William Johnston is a Urologist practicing medicine in Brighton, Michigan. He has been practicing medicine for over 29 years. Dr. Johnston is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 49 other conditions, according to our data. His clinical expertise encompasses Renal Oncocytoma, Prostate Cancer, Enlarged Prostate (BPH), Pelvic Laparoscopy, and Ureteroscopy. Dr. Johnston is board certified in American Board Of Urology. Dr. Johnston is currently accepting new patients.

Anne Pelletier Cameron, MD, FRCSC, FPMRS, the James Montie Legacy Professor of Urology at the University of Michigan and Associate Chair of Quality and Safety and Service Chief for the Department of Urology, and director of the Clinical Urology Research Endeavor (CURE). She received her undergraduate degree at the University of New Brunswick. After completing her medical degree at the University of Ottawa and residency in urology at Dalhousie University, Dr. Cameron came to the University of Michigan for a fellowship in Female Pelvic Medicine and Reconstruction. Dr. Cameron remains at the university as an active clinician and participates in several research trials, including the NIDDK Funded LURN. Her clinical interests include complex incontinence, female urethral disease, and the care of neurogenic bladder. She also has a strong interest in medical education and is associate fellowship director and clerkship director for the urology residency.Dr. Cameron is active with the Society of Women in Urology, serving as the president and as the annual meeting planner and active with the AUA serving on the Core Curriculum and a member on the Neurologic Lower Urinary Tract Dysfunction Guideline Committee. Dr. Cameron has also been very active with SUFU serving on the Executive Committee and the SUFU Urodynamics Antibiotic Prophylaxis Task Force and awarded the Paul Zimskind research award in 2018. Dr. Cameron is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Urinary Incontinence, Neurogenic Bladder, Interstitial Cystitis, and Urinary Tract Infection (UTI). Dr. Cameron is board certified in Urology and Female Pelvic Medicine & Reconstructive Surg.

Gregory Oldford is a Urologist practicing medicine in Brighton, Michigan. Dr. Oldford is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Prostate Cancer, Familial Prostate Cancer, UPJ Obstruction, and Ureteroscopy.

Joshua Palka is a Urologist practicing medicine in Brighton, Michigan. He has been practicing medicine for over 11 years. Dr. Palka is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Obstructive Uropathy, Urinary Tract Infection (UTI), Congenital Mesoblastic Nephroma, Nephrectomy, and Ureteroscopy. Dr. Palka is board certified in American Board Of Urology. Dr. Palka is currently accepting new patients.

Dr. Sarah Yentz received her medical degree from the University of Michigan and completed Internal Medicine residency training at Northwestern Memorial Hospital where she served as chief resident 2014-2015. She completed her fellowship in Hematology/Oncology at the University of Michigan in 2018. Dr. Yentz is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, and WT1-Related Wilms Tumor Syndromes.

Dr. Rakesh Latchamsetty is a Clinical Assistant Professor in the Division of Electrophysiology at the University of Michigan Hospital. He has completed his training in Clinical Cardiac Electrophysiology at the University of Michigan and has since remained as faculty. He is active clinically at the University of Michigan Hospital in Ann Arbor as well as the Ann Arbor Veterans Affairs Medical Center. He has also established the Arrhythmia Clinic at the University of Michigan Brighton Health Center.Dr. Latchamsetty’s academic interests include research into mechanisms of atrial fibrillation and signal analysis, outcomes and techniques of ablation of atrial and ventricular arrhythmias, and database development and management. He is also involved in clinical trials evaluating defibrillator and pacemaker technology. His works include publications in peer reviewed journals as well as book chapters. He is also actively involved in the General Cardiology and Clinical Cardiac Electrophysiology Fellowship training programs. Dr. Latchamsetty is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 55 other conditions, according to our data. His clinical expertise encompasses Ectopic Heartbeat, Arrhythmias, Ventricular Tachycardia, Cardiac Ablation, and Pacemaker Implantation. Dr. Latchamsetty is board certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology.

Dr. Farrehi is presently Assistant Professor of Medicine in the Division of Cardiovascular Medicine, a position he has held since 2009. He received his undergraduate degree from Haverford College and medical degree from Emory University. He then completed an internship and residency in Internal Medicine at the University of Michigan. A clinical cardiology fellowship was performed also at the University of Michigan between 1994-1998. After completing clinical cardiology training, Dr. Farrehi went back to Emory University to finish an interventional cardiology fellowship. Dr. Farrehi has an interest in all fields of clinical cardiology. In particular, he is interested in studying the association of sleep breathing disorders in patients with heart disease. Currently, he also serves as the Medical Director on 7C M-PLAN , (Medical directors Partnering to Lead Along with Nurse managers), an initiative formalized by the Office of Clinical Affairs, aspiring to the ideas espoused in the Health System’s Ideal Patient Care Experience. He has been appointed as Director of Strategic Outreach for the Division to work with institutional leadership and outreach committees in developing optimal framework for building relationships between academic and community hospitals. Dr. Farrehi is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 59 other conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Heart Attack, Aortic Valve Stenosis, Cardiac Ablation, and Pacemaker Implantation.

I came to the University of Michigan as a Robert Wood Johnson Clinical Scholar in 1997, following the completion of my urologic training at Cornell University-New York Hospital. During the fellowship, I also obtained a Masters degree in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health. Even more importantly, I was inspired by my mentors including Rodney Hayward and James Montie to train others to conduct high quality research. I then stayed on to join the University of Michigan faculty as an Assistant Professor in 1999. In 2004, I was promoted to Associate Professor, and in 2009, I was promoted to Professor of Urology. Dr. Wei is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Enlarged Prostate (BPH), Urinary Incontinence, Prostatectomy, and Cystectomy. Dr. Wei is board certified in Urology.

Dr. Singhal is a board-eligible urologic oncologist who specializes in the management of patients with kidney, prostate, bladder, testis, upper tract urothelial, and penile cancers. He completed his residency training in urology at the University of Michigan in Ann Arbor, MI, and his research fellowship training in translational science at the University of Michigan. He then completed his clinical urological oncology fellowship at the Mayo Clinic in Rochester, MN. He performs advanced open, endoscopic, laparoscopic, and robotic surgery. Dr. Singhal’s research interests include the development and implementation of novel, precision-based diagnostics and therapeutics in all genitourinary malignancies. He has a special interest in the integration of genomics into biomarker-driven clinical trials in oncology, with the goal of optimally defining the clinical application of these tests. He has received grant funding for his research from the National Institutes of Health, National Cancer Institute, Prostate Cancer Foundation, Urology Care Foundation, University of Michigan, and industry partners. He has additionally received top honors and awards for his research from the Prostate Cancer Foundation, Urology Care Foundation, American Society of Clinical Oncology, and American Association for Cancer Research. He also serves as peer reviewer for many leading academic journals and is a member of numerous professional societies, including the American Urological Association, Society of Urologic Oncology, SWOG Cancer Research Network, SUO Clinical Trials Consortium, and the American Society of Clinical Oncology. Dr. Singhal is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Choriocarcinoma, Testicular Cancer, Prostatectomy, and Nephrectomy.

Dr. Ambani is a native mid-Michigander, having grown up in Jackson, MI. After receiving his undergraduate degree from Harvard University, he obtained his medical degree from the University of Pittsburgh School of Medicine. He subsequently completed his Urology residency at the University of Michigan, and then stayed on to complete a fellowship in Laparoscopy, Robotics, and Stone Surgery. He subsequently joined the Endourology division of the University of Michigan Health System Department of Urology. His clinical interests include minimally-invasive surgery of the kidney and ureter, including ureteropelvic junction (UPJ) obstruction, ureteral scarring/injury, complex ureteral reconstruction using small incisions, and kidney stone surgery. He performs a high volume of surgery to repair UPJ obstruction and complex ureteral strictures from scarring due to surgical history or stone disease. Dr. Ambani understands that patients with ureteral disease have faced multiple unexpected issues, and approached this challenging clinical with compassion and understanding. Based on his clinical experience, he is a nationally recognized expert in this field and has multiple publications investigating the optimal approach to surgical repair of ureteral disease. He serves as the head of the University of Michigan Ureteral Reconstruction Working Group, which aims to improve the care of patients who require ureteral reconstruction surgery through clinical collaboration and research. Based on this work, he has a shared appointment in the division of Neurourology and Pelvic Reconstruction within the Department of Urology.He also serves as the Associate Residency Program Director for the Department of Urology. He also serves as the Surgical Director of the University Hospital Operating Rooms. Dr. Ambani is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Retroperitoneal Fibrosis, Intussusception in Children, Obstructive Uropathy, Nephrectomy, and Ureteral Reconstruction. Dr. Ambani is board certified in Urology.

Dr. Dragovic attended the University of Michigan for both undergraduate and medical school, and after completing radiation oncology residency at the University of Alabama at Birmingham (UAB), he returned to Ann Arbor to join the U of M Department of Radiation Oncology faculty in 2012. Since that time, he has held several roles in the Department of Radiation Oncology, with experience in multiple of the department’s community practice affiliates as well as at the main hospital. Dr. Dragovic was chosen to lead the department’s new clinic at the Brighton Center for Specialty Care and also to represent the BCSC Cancer Center as a whole as Physician Lead. He has taken on these roles with great joy and pride as it has been both a challenge and reward being a part of building a new cancer center. Dr. Dragovic’s vision for the BCSC Cancer Center is to become more or less an extension of the University Hospital Cancer Center- providing the highest quality multidisciplinary care to patients with a wide variety of cancer diagnoses, including the availability of clinical trial enrollment for appropriate patients. Clinically, Dr. Dragovic treats all disease sites and has a specific clinical interest in head & neck cancer, lung cancer, and stereotactic body radiotherapy (SBRT). Dr. Dragovic is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Laryngeal Cancer, and Breast Cancer. Dr. Dragovic is board certified in Radiation Oncology.

John C. Krauss, M.D., graduated from the University of Michigan Medical School in 1985, did his Internal Medicine training at the University of Minnesota, and then returned to the University of Michigan for his Hematology and Oncology specialty training. Dr. Krauss joined the University of Michigan Faculty in 1992, and then moved his research lab to the Cleveland Clinic to continue clinical research on harnessing the immune system to combat cancer. In 1998, Dr. Krauss came back to Ann Arbor to be the Associate Director of the Ann Arbor Community Cancer Oncology Program at St. Joseph Mercy Hospital, and rose through the ranks to be the Section Head of Hematology/Oncology. Dr. Krauss treats a wide variety of patients with cancer, including breast cancer, colon cancer, lung cancer, and kidney cancer, focusing both on providing the highest possible cure rates for cancer and the best quality of life for the patient while on the journey. Dr. Krauss is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Anal Cancer. Dr. Krauss is board certified in Internal Medicine and Medical Oncology.

Dr Joseph Evans is originally from the Chicago suburbs, and attended the University of Iowa where he graduated with a Bachelor of Science degree in Physics. He then completed the MD-PhD program at Northwestern University Feinberg School of Medicine, where his graduate studies focused on inhibitors of cell death in cancer cells. Dr Evans entered Radiation Oncology at University of Michigan where he completed Residency.Clinically, Dr Evans sees and treats patients with gynecologic cancer, including brachytherapy, spine metastases, and benign diseases treated with radiation treatment, particularly Dupuytren's disease.Dr Evans is a physician leader in the department and the Rogel Cancer Center. He works with other faculty and staff leaders on clinical operations within the department and the interface with the Cancer Center, focusing on process improvement, quality metrics, financial stewardship, and strategy. His work streamlines workflows in the Electronic Medical Record (Epic) to improve patient care, patient experience, and clinician experience. Dr. Evans is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, and Prostate Cancer. Dr. Evans is board certified in Radiation Oncology.

Kimberly Morley is a Hematologist practicing medicine in Brighton, Michigan. Dr. Morley is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, and Lung Cancer.

Steven Thiry is a primary care provider, practicing in Family Medicine in Brighton, Michigan. Dr. Thiry is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Blood Clots, Type 2 Diabetes (T2D), and Non-Muscle Invasive Bladder Cancer.

Jennifer Kuo is a Urologist practicing medicine in Howell, Michigan. She has been practicing medicine for over 10 years. Dr. Kuo is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her clinical expertise encompasses UPJ Obstruction, Bilateral Hydronephrosis, Kidney Stones, Boils, and Ureteroscopy.

Roger Gonda is a Radiologist practicing medicine in Novi, Michigan. Dr. Gonda is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Ascites, Cerebral Arteriovenous Malformation, Nasal Flaring, and Visceromegaly.

Michael Lehmann is a Cardiologist practicing medicine in Northville,, Michigan. Dr. Lehmann is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Familial Ventricular Tachycardia, Arrhythmias, Necrosis, and Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).